Zobrazeno 1 - 10
of 3 609
pro vyhledávání: '"DUNN DT"'
Autor:
Chu IY; Institute for Global Health, University College London, Royal Free Hospital, Rowland Hill Street, NW3 2PF, London, UK. isaac.yh.chu@ucl.ac.uk.; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, WC1H 9SH, London, UK. isaac.yh.chu@ucl.ac.uk., Weatherburn P; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, WC1H 9SH, London, UK., Wright T; Division of Psychiatry, University College London, 149 Tottenham Court Rd, W1T 7BN, London, UK., Samba P; The Love Tank CIC, The Green House, 244-254 Cambridge Heath Road, E2 9DA, London, UK., Nicholls EJ; Institute for Global Health, University College London, Royal Free Hospital, Rowland Hill Street, NW3 2PF, London, UK., McCabe L; Medical Research Council Clinical Trials Unit at University College London, 90 High Holborn, WC1V 6LJ, London, UK., Gafos M; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, WC1H 9SH, London, UK., Dunn DT; Medical Research Council Clinical Trials Unit at University College London, 90 High Holborn, WC1V 6LJ, London, UK., Trevelion R; HIV i-Base, 107 The Maltings, 169 Tower Bridge Road, SE1 3LJ, London, UK., Burns FM; Institute for Global Health, University College London, Royal Free Hospital, Rowland Hill Street, NW3 2PF, London, UK., Rodger AJ; Institute for Global Health, University College London, Royal Free Hospital, Rowland Hill Street, NW3 2PF, London, UK., Witzel TC; Institute for Global Health, University College London, Royal Free Hospital, Rowland Hill Street, NW3 2PF, London, UK.; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, WC1H 9SH, London, UK.
Publikováno v:
BMC public health [BMC Public Health] 2024 Jul 25; Vol. 24 (1), pp. 1984. Date of Electronic Publication: 2024 Jul 25.
Autor:
Tweed CD; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., Quartagno M; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., Clements MN; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., Turner RM; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., Nunn AJ; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., Dunn DT; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., White IR; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK., Copas AJ; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London WC1V 6LJ, UK.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2024 Jun 17; Vol. 385, pp. e078000. Date of Electronic Publication: 2024 Jun 17.
Autor:
Paton NI; MRC Clinical Trials Unit at University College London, London, UK.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Stöhr W; MRC Clinical Trials Unit at University College London, London, UK., Arenas-Pinto A; MRC Clinical Trials Unit at University College London, London, UK., Clarke A; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Williams I; University College London, UK., Johnson M; Royal Free Hospital, London, UK., Orkin C; Barts and the Royal London Hospital NHS Trust, London, UK., Chen F; Royal Berkshire Hospital, Reading, UK., Lee V; Manchester Royal Infirmary, UK., Winston A; St Mary's Hospital, London, UK., Gompels M; Southmead Hospital, Bristol, UK., Fox J; Guys and St. Thomas' Hospital, London, UK., Sanders K; MRC Clinical Trials Unit at University College London, London, UK., Dunn DT; MRC Clinical Trials Unit at University College London, London, UK.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2024 Feb 10; Vol. 69, pp. 102457. Date of Electronic Publication: 2024 Feb 10 (Print Publication: 2024).
Autor:
Szubert, AJ, Pollock, KM, Cheeseman, HM, Alagaratnam, J, Bern, H, Bird, O, Boffito, M, Byrne, R, Cole, T, Cosgrove, CA, Faust, SN, Fidler, S, Galiza, E, Hassanin, H, Kalyan, M, Libri, V, McFarlane, LR, Milinkovic, A, O'Hara, J, Owen, DR, Owens, D, Pacurar, M, Rampling, T, Skene, S, Winston, A, Woolley, J, Yim, YTN, Dunn, DT, McCormack, S, Shattock, RJ, COVAC 1 Study Team
Publikováno v:
eClinicalMedicine. 56:101823
Background: lipid nanoparticle (LNP) encapsulated self-amplifying RNA (saRNA) is well tolerated and immunogenic in SARS-CoV-2 seronegative and seropositive individuals aged 18–75. Methods: a phase 2a expanded safety and immunogenicity study of a sa
Autor:
Dunn DT; Institute for Global Health, University College London, London, UK; MRC Clinical Trials Unit, University College London, London, UK. Electronic address: d.dunn@ucl.ac.uk., Gilson R; Institute for Global Health, University College London, London, UK., McCormack S; MRC Clinical Trials Unit, University College London, London, UK., McCoy LE; Institute of Immunity and Transplantation, Division of Infection & Immunity, University College London, London, UK.
Publikováno v:
Vaccine [Vaccine] 2023 Jul 12; Vol. 41 (31), pp. 4472-4479. Date of Electronic Publication: 2023 Jun 16.
Autor:
Dunn DT; Institute for Global Health, University College London, London, UK. d.dunn@ucl.ac.uk.; MRC Clinical Trials Unit, University College London, 90 High Holborn, London, WC1V 6LJ, UK. d.dunn@ucl.ac.uk., Stirrup OT; Institute for Global Health, University College London, London, UK., McCormack S; MRC Clinical Trials Unit, University College London, 90 High Holborn, London, WC1V 6LJ, UK., Glidden DV; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Publikováno v:
BMC medical research methodology [BMC Med Res Methodol] 2023 Jun 26; Vol. 23 (1), pp. 149. Date of Electronic Publication: 2023 Jun 26.
Autor:
Witzel, TC, Bourne, A, Burns, FM, Rodger, AJ, McCabe, L, Gabriel, MM, Gafos, M, Ward, D, Collaco-Moraes, Y, Dunn, DT, Speakman, A, Bonell, C, Pebody, R, Lampe, FC, Harbottle, J, Phillips, AN, McCormack, S, Weatherburn, P
OBJECTIVES: SELPHI (HIV Self-Testing Public Health Intervention) is the largest randomized controlled trial (RCT) of HIV self-testing (HIVST) in a high-income setting to date, and has recruited 10 000 men who have sex with men (cis- and transgender)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::070e0005f661c498c486bc7d60ba2de7
https://researchonline.lshtm.ac.uk/id/eprint/4655562/1/Witzel-HIVST-intervention-experiences-and-kit-usability.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4655562/1/Witzel-HIVST-intervention-experiences-and-kit-usability.pdf
Autor:
Stirrup, OT, Sabin, CA, Phillips, AN, Williams, I, Churchill, D, Tostevin, A, Hill, T, Dunn, DT, Asboe, D, Pozniak, A, Cane, P, Chadwick, D, Clark, D, Collins, S, Delpech, V, Douthwaite, S, Dunn, D, Fearnhill, E, Porter, K, Stirrup, O, Fraser, C, Geretti, AM, Gunson, R, Hale, A, Hue, S, Lazarus, L, Leigh-Brown, A, Mbisa, T, Mackie, N, Orkin, C, Nastouli, E, Pillay, D, Phillips, A, Sabin, C, Smit, E, Templeton, K, Tilston, P, Volz, E, Zhang, H, Fairbrother, K, Dawkins, J, O'Shea, S, Mullen, J, Cox, A, Tandy, R, Fawcett, T, Hopkins, M, Booth, C, Garcia-Diaz, A, Renwick, L, Schmid, ML, Payne, B, Hubb, J, Dustan, S, Kirk, S, Bradley-Stewart, A, Ainsworth, J, Allan, S, Anderson, J, Babiker, A, Gazzard, B, Gilson, R, Compels, M, Hay, P, Johnson, M, Jose, S, Kegg, S, Leen, C, Martin, F, Mital, D, Nelson, M, Palfreeman, A, Post, F, Pritchard, J, Schwenk, A, Tariq, A, Trevelion, R, Ustianowski, A, Walsh, J, Thornton, A, Huntington, S, Glabay, A, Shidfar, S, Lynch, J, Hand, J, De Souza, C, Perry, N, Tilbury, S, Youssef, E, Mabika, T, Mandalia, S, Munshi, S, Adefisan, A, Taylor, C, Gleisner, Z, Ibrahim, F, Campbell, L, Baillie, K, Brima, N, Miller, S, Wood, C, Youle, M, Lampe, F, Smith, C, Tsintas, R, Chaloner, C, Hutchinson, S, Winston, A, Weber, J, Ramzan, F, Carder, M, Wilson, A, Morris, S, Gompels, M, Lewszuk, A, Faleye, A, Ogunbiyi, V, Mitchell, S, Kemble, C, Russell-Sharpe, S, Gravely, J, Harte, A, Spencer, H, Jones, R, Cumming, S, Atkinson, C, Edgell, V, Allen, J, Murphy, C, Gunder, I
Objectives The aim of this study was to investigate associations between baseline characteristics and CD4 cell count response on first-line antiretroviral therapy and risk of virological failure (VF) with or without drug resistance. Methods We conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::5d0978d4e2a8857878cd16b0f46241f0
http://hdl.handle.net/10044/1/80736
http://hdl.handle.net/10044/1/80736
Autor:
Stirrup, OT, Asboe, D, Pozniak, A, Sabin, CA, Gilson, R, Mackie, NE, Tostevin, A, Hill, T, Dunn, DT, Chadwick, David, Churchill, Duncan, Clark, Duncan, Collins, Simon, Delpech, Valerie, Douthwaite, Samuel, Fearnhill, Esther, Porter, Kholoud, Fraser, Christophe, Geretti, Anna Maria, Gunson, Rory
Publikováno v:
HIV Medicine; May2020, Vol. 21 Issue 5, p309-321, 13p
Autor:
Witzel, TC, Bourne, A, Burns, FM, Rodger, AJ, McCabe, L, Gabriel, MM, Gafos, M, Ward, D, Collaco‐Moraes, Y, Dunn, DT, Speakman, A, Bonell, C, Pebody, R, Lampe, FC, Harbottle, J, Phillips, AN, McCormack, S, Weatherburn, P
Publikováno v:
HIV Medicine; Mar2020, Vol. 21 Issue 3, p189-197, 9p